Your session is about to expire
← Back to Search
Behavioural Intervention
Treatment for Ventricular Tachycardia
N/A
Waitlist Available
Led By Kalyanam Shivkumar, MD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 minutes or completion of the vagus nerve stimulation
Awards & highlights
Study Summary
This trial will help researchers learn more about how VNS affects abnormal heart rhythms, which could lead to new therapies for patients with life-threatening ventricular arrhythmias.
Eligible Conditions
- Ventricular Tachycardia
- Arrhythmia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 minutes or completion of the vagus nerve stimulation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 minutes or completion of the vagus nerve stimulation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The change in ventricular action potential duration during stimulation compared to baseline in msec
Secondary outcome measures
The change in blood pressure during stimulation compared to baseline in mmHg.
The change in heart rate during stimulation compared to baseline in beats per minute
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,846 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,583 Total Patients Enrolled
Kalyanam Shivkumar, MD, PhD2.85 ReviewsPrincipal Investigator - University of California, Los Angeles
University of California, Los Angeles
2 Previous Clinical Trials
10,040 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your heart beats regularly and is faster than 50 beats per minute.You currently have signs of heart problems like chest pain, abnormal ECG results, or blocked heart arteries. If you have high troponin levels due to having an internal cardiac defibrillator, it will not exclude you from the study.You have had a heart transplant.You have certain types of heart conditions such as long QT syndrome, Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia.You have a history of nerve problems outside of the heart.You have severe heart failure or are currently taking certain medications for blood pressure.You have continuous episodes of ventricular tachycardia.You have ongoing atrial fibrillation.You have frequent early or extra heartbeats.You have a heart condition that affects the pumping function of your heart or causes abnormal heart muscle growth.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being accepted for this clinical experiment at present?
"Affirmative, the clinicaltrials.gov database confirms that recruitment for this study is ongoing. It was originally posted on December 8th 2020 and has been updated as recently as September 27th 2022. The trial aims to enrol 6 participants at 1 site in total."
Answered by AI
What is the maximum capacity for participants in this research experiment?
"Affirmative. Data posted on clinicaltrials.gov states that this experiment is presently seeking volunteers. It was first announced to the public on December 8th 2020 and has been updated as recently as September 27th 2022, with a need for 6 individuals at 1 site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger